Literature DB >> 20299445

Video-assisted thoracic surgery for pulmonary aspergilloma.

Junji Ichinose1, Tadasu Kohno, Sakashi Fujimori.   

Abstract

The purpose of this retrospective study was to review our experience with video-assisted thoracic surgery (VATS) for pulmonary aspergilloma. The patients (n=20) were aged 62+/-12 years, and eight (40%) were aged 70 years or more. The disease types were simple aspergilloma (SA) in six patients and complex aspergilloma (CA) in 14. The surgical procedures performed were lobectomy in 14 patients, segmentectomy in two, and wedge resection in four. The operation time was shorter (143+/-69 min vs. 216+/-85 min; P=0.08) and the blood loss was less (10+/-17 ml vs. 307+/-346 ml; P<0.01) for patients with SA than those with CA. Postoperative death occurred in one patient with CA who developed a bronchial stump fistula (30-day mortality; 5.0%). During follow-up, three patients died from other non-disease-related causes, and the remaining 17 patients survived without recurrence. The 5-year survival rate was 89%. In suitable cases, VATS for pulmonary aspergilloma may not be inferior to open surgery with regard to safety and efficacy. In particular, SA is considered to be a good indication for VATS.

Entities:  

Mesh:

Year:  2010        PMID: 20299445     DOI: 10.1510/icvts.2009.232066

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  16 in total

1.  Pulmonary infections imitating lung cancer: clinical presentation and therapeutical approach.

Authors:  M Schweigert; A Dubecz; M Beron; D Ofner; H J Stein
Journal:  Ir J Med Sci       Date:  2012-05-17       Impact factor: 1.568

2.  Video-assisted thoracoscopic surgery is a safe option for benign lung diseases requiring lobectomy.

Authors:  Antonio Mazzella; Anne Olland; Elena Garelli; Stephane Renaud; Jeremie Reeb; Nicola Santelmo; Pierre Emmanuel Falcoz; Gilbert Massard
Journal:  Surg Endosc       Date:  2016-07-12       Impact factor: 4.584

3.  Is video-assisted thoracic surgery a versatile treatment for both simple and complex pulmonary aspergilloma?

Authors:  Ping Yuan; Zhitian Wang; Feichao Bao; Yunhai Yang; Jian Hu
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

Review 4.  VATS segmentectomy: past, present, and future.

Authors:  Seshiru Nakazawa; Kimihiro Shimizu; Akira Mogi; Hiroyuki Kuwano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-12-18

5.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

6.  Robotic assisted thoracoscopic right upper lobectomy for post tuberculosis aspergilloma.

Authors:  Ali Zamir Khan; Kamran Ali; Shaiwal Khandelwal; Narendra Agarwal; Mohd Fauzi Jamaluddin; Sangeeta Khanna; Preety Roy
Journal:  J Vis Surg       Date:  2016-03-14

Review 7.  Video-assisted thoracoscopic surgery and open chest surgery in infectious lung diseases.

Authors:  Agasthian Thirugnanam
Journal:  J Vis Surg       Date:  2017-01-06

8.  Video-assisted thoracoscopic surgery for invasive pulmonary fungal infection in haematology patients.

Authors:  Han Ma; Jun Wang; Xiao Ma; Shiying Zheng; Haitao Ma; Jinfeng Ge
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

9.  Surgery for hemoptysis in patients with benign lung disease.

Authors:  Ju Sik Yun; Sang Yun Song; Kook Joo Na; Seok Kim; Keun-Ho Jang; In Seok Jeong; Sang Gi Oh
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

10.  Is adjuvant antifungal therapy after video-assisted thoracic surgery for pulmonary aspergilloma necessary?

Authors:  Shuo Zheng; Xin Li; Bin Hu; Hui Li
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.